The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles

Neuropathology and Applied Neurobiology

Volumn 36, Issue 4, 2010, Pages 275-284

  Massa, R ^a,b   Panico, M B ^a,b   Caldarola, S ^a   Fusco, F R ^b   Sabatelli, P ^d   Terracciano, C ^a   Botta, A ^a   Novelli, G ^a,c   Bernardi, G ^a,b   Loreni, F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c Department of Ophthalmology   (Italy)

^d CNR   (Italy)

Author keywords

DM2; Immunocytochemistry; Myotonic dystrophy type 2; Skeletal muscle; Zinc finger protein 9; ZNF9

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 9; CNBP PROTEIN, HUMAN; CNBP1 PROTEIN, RAT; CONNECTIN; MUSCLE PROTEIN; PROTEIN KINASE; RNA BINDING PROTEIN; TTN PROTEIN, HUMAN;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE FIBRIL; MYOTONIC DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RABBIT; RAT; SARCOMERE; THIN FILAMENT; TISSUE DISTRIBUTION; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MUSCLE; NERVE FIBER; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE; WESTERN BLOTTING;

ANIMALS; AXONS; BLOTTING, WESTERN; CONNECTIN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, IMMUNOELECTRON; MUSCLE PROTEINS; MUSCLES; MYOTONIC DYSTROPHY; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; RNA-BINDING PROTEINS; SARCOMERES;

EID: 77952375211     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2010.01068.x     Document Type: Article

References (47)

1. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992 68 : 799 808
2. Fu YH, Pizzuti A, Fenwick RG Jr., King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992 255 : 1256 1258
3. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earle-Macdonald J, de Jong PJ, Wieringa B, Korneluk RG. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 1992 255 : 1253 1255
4. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001 293 : 864 867
5. Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW. Genetic mapping of a second myotonic dystrophy locus. Nat Genet 1998 19 : 196 198
6. Cho DH, Tapscott SJ. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 2007 1772 : 195 204
7. Day JW, Ranum LP. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 2005 15 : 5 16
8. Mankodi A, Teng-Umnuay P, Krym M, Henderson D, Swanson M, Thornton CA. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 2003 54 : 760 768
9. Ishiura S, Kino Y, Nezu Y, Onishi H, Ohno E, Sasagawa N. Regulation of splicing by MBNL and CELF family of RNA-binding protein. Acta Myol 2005 24 : 74 7
10. Botta A, Vallo L, Rinaldi F, Bonifazi E, Amati F, Biancolella M, Gambardella S, Mancinelli E, Angelini C, Meola G, Novelli G. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2. Gene Expr 2007 13 : 339 351
11. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. A muscleblind knockout model for myotonic dystrophy. Science 2003 302 : 1978 1980
12. Philips AV, Timchenko LT, Cooper TA. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998 280 : 737 741
13. Ho TH, Bundman D, Armstrong DL, Cooper TA. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 2005 14 : 1539 1547
14. Mahadevan MS, Yadava RS, Yu Q, Balijepalli S, Frenzel-McCardell CD, Bourne TD, Phillips LH. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat Genet 2006 38 : 1066 1070
15. Bassez G, Chapoy E, Bastuji-Garin S, Radvanyi-Hoffman H, Authier FJ, Pellissier JF, Eymard B, Gherardi RK. Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fibre central nucleation and scattered atrophy. J Neuropathol Exp Neurol 2008 67 : 319 325
16. Pisani V, Panico MB, Terracciano C, Bonifazi E, Meola G, Novelli G, Bernardi G, Angelini C, Massa R. Preferential central nucleation of type 2 myofibers is an invariable feature of myotonic dystrophy type 2. Muscle Nerve 2008 38 : 1405 1411
17. Abbruzzese C, Costanzi PS, Mariani B, Gould FK, McAbney JP, Monckton DG, Ashizawa T, Giacanelli M. Instability of a premutation allele in homozygous patients with myotonic dystrophy type 1. Ann Neurol 2002 52 : 435 441
18. Martorell L, Illa I, Rosell J, Benitez J, Sedano MJ, Baiget M. Homozygous myotonic dystrophy: clinical and molecular studies of three unrelated cases. J Med Genet 1996 33 : 783 785
19. Schoser BG, Kress W, Walter MC, Halliger-Keller B, Lochmuller H, Ricker K. Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain 2004 127 : 1868 1877 (Pubitemid 39061562)
20. Eriksson M, Hedberg B, Carey N, Ansved T. Decreased DMPK transcript levels in myotonic dystrophy 1 type IIA muscle fibres. Biochem Biophys Res Commun 2001 286 : 1177 1182
21. Furling D, Lemieux D, Taneja K, Puymirat J. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul Disord 2001 11 : 728 735
22. Reddy S, Smith DB, Rich MM, Leferovich JM, Reilly P, Davis BM, Tran K, Rayburn H, Bronson R, Cros D, Balice-Gordon RJ, Housman D. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 1996 13 : 325 335
23. Berul CI, Maguire CT, Aronovitz MJ, Greenwood J, Miller C, Gehrmann J, Housman D, Mendelsohn ME, Reddy S. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J Clin Invest 1999 103 : R1 7
24. Chen W, Wang Y, Abe Y, Cheney L, Udd B, Li YP. Haploinsuffciency for Znf9 in Znf9+/- mice is associated with multiorgan abnormalities resembling myotonic dystrophy. J Mol Biol 2007 368 : 8 17
25. Rajavashisth TB, Taylor AK, Andalibi A, Svenson KL, Lusis AJ. Identification of a zinc finger protein that binds to the sterol regulatory element. Science 1989 245 : 640 643
26. De Dominicis A, Lotti F, Pierandrei-Amaldi P, Cardinali B. cDNA cloning and developmental expression of cellular nucleic acid-binding protein (CNBP) gene in Xenopus laevis. Gene 2000 241 : 35 43
27. Flink IL, Morkin E. Organization of the gene encoding cellular nucleic acid-binding protein. Gene 1995 163 : 279 282
28. Ruble DM, Foster DN. Molecular cloning and characterization of a highly conserved chicken cellular nucleic acid binding protein cDNA. Gene 1998 218 : 95 101
29. Warden CH, Krisans SK, Purcell-Huynh D, Leete LM, Daluiski A, Diep A, Taylor BA, Lusis AJ. Mouse cellular nucleic acid binding proteins: a highly conserved family identified by genetic mapping and sequencing. Genomics 1994 24 : 14 19
30. van Heumen WR, Claxton C, Pickles JO. Sequence and tissue distribution of chicken cellular nucleic acid binding protein cDNA. Comp Biochem Physiol B Biochem Mol Biol 1997 118 : 659 665
31. Flink IL, Morkin E. Alternatively processed isoforms of cellular nucleic acid-binding protein interact with a suppressor region of the human beta-myosin heavy chain gene. J Biol Chem 1995 270 : 6959 6965
32. Michelotti EF, Tomonaga T, Krutzsch H, Levens D. Cellular nucleic acid binding protein regulates the CT element of the human c-myc protooncogene. J Biol Chem 1995 270 : 9494 9499
33. Chen W, Liang Y, Deng W, Shimizu K, Ashique AM, Li E, Li YP. The zinc-finger protein CNBP is required for forebrain formation in the mouse. Development 2003 130 : 1367 1379
34. Bonifazi E, Vallo L, Giardina E, Botta A, Novelli G. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2. Diagn Mol Pathol 2004 13 : 164 166
35. Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, Surmeier DJ, Honig MG, Carlock LR, Reiner A. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J Neurosci 1999 19 : 1189 1202
36. Massa R, Castellani L, Silvestri G, Sancesario G, Bernardi G. Dystrophin is not essential for the integrity of the cytoskeleton. Acta Neuropathol 1994 87 : 377 384
37. Fusco FR, Zuccato C, Tartari M, Martorana A, De MZ, Giampa C, Cattaneo E, Bernardi G. Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain. Eur J Neurosci 2003 18 : 1093 1102
38. Botta A, Caldarola S, Vallo L, Bonifazi E, Fruci D, Gullotta F, Massa R, Novelli G, Loreni F. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2). Biochim Biophys Acta 2006 1762 : 329 334
39. Furst DO, Osborn M, Nave R, Weber K. The organization of titin filaments in the half-sarcomere revealed by monoclonal antibodies in immunoelectron microscopy: a map of ten nonrepetitive epitopes starting at the Z line extends close to the M line. J Cell Biol 1988 106 : 1563 1572
40. Klug A, Rhodes D. Zinc fingers: a novel protein fold for nucleic acid recognition. Cold Spring Harb Symp Quant Biol 1987 52 : 473 482
41. Krempler A, Brenig B. Zinc finger proteins: watchdogs in muscle development. Mol Gen Genet 1999 261 : 209 215
42. Huichalaf C, Schoser B, Schneider-Gold C, Jin B, Sarkar P, Timchenko L. Reduction of the rate of protein translation in patients with myotonic dystrophy 2. J Neurosci 2009 29 : 9042 9049
43. Pellizzoni L, Lotti F, Maras B, Pierandrei-Amaldi P. Cellular nucleic acid binding protein binds a conserved region of the 5′ UTR of Xenopus laevis ribosomal protein mRNAs. J Mol Biol 1997 267 : 264 275
44. Gerbasi VR, Link AJ. The myotonic dystrophy type 2 protein ZNF9 is part of an ITAF complex that promotes cap-independent translation. Mol Cell Proteomics 2007 6 : 1049 1058
45. Margolis JM, Schoser BG, Moseley ML, Day JW, Ranum LP. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum Mol Genet 2006 15 : 1808 1815
46. Pelletier R, Hamel F, Beaulieu D, Patry L, Haineault C, Tarnopolsky M, Schoser B, Puymirat J. Absence of a differentiation defect in muscle satellite cells from DM2 patients. Neurobiol Dis 2009 36 : 181 190
47. Zhou A, Zhou J, Yang L, Liu M, Li H, Xu S, Han M, Zhang J. A nuclear localized protein ZCCHC9 is expressed in cerebral cortex and suppresses the MAPK signal pathway. J Genet Genomics 2008 35 : 467 472